Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Boostrix-IPV inj 0.5ml pre-filled syringes
1404000F0BPAAAX
|
Boostrix-IPV | Diphtheria | Immunological Products and Vaccines | 47 |
|
Fluenz Tetra vaccine nasal suspension 0.2ml unit dose
1404000H0BRABAJ
|
Fluenz | Influenza | Immunological Products and Vaccines | 47 |
|
Hepatitis B (rDNA) 20micrograms/0.5ml vacc inj pfs
1404000G0AAAJAJ
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 43 |
|
Repevax vacc inj 0.5ml pre-filled syringes
1404000F0BMAAAX
|
Repevax | Diphtheria | Immunological Products and Vaccines | 42 |
|
Meningococcal polysacch A, C, W135 and Y conj vacc inj 0.5ml
1404000X0AAAGAG
|
Meningococcal A, C,W135 and Y vaccine | Meningococcal A + C + W135 + Y vaccine | Immunological Products and Vaccines | 31 |
|
Pneumococcal polysacch conj vacc (ads) inj 0.5ml pfs
1404000L0AAAFAF
|
Pneumococcal | Pneumococcal | Immunological Products and Vaccines | 29 |
|
Vaxchora vaccine effervescent powder and powder for susp
1404000E0BGAAAK
|
Vaxchora | Cholera | Immunological Products and Vaccines | 26 |
|
Havrix Junior Monodose vacc inj 0.5ml vials
140400030BBAFAJ
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 23 |
|
Trivalent Flu/Vac/Split High Dose inj 0.5ml pfs
1404000H0CBAAAL
|
Trivalent | Influenza | Immunological Products and Vaccines | 23 |
|
Hepatitis B (rDNA) 40micrograms/1ml vacc inj vials
1404000G0AAAGAG
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 21 |
|
Hepatitis B (rDNA) 5micrograms/0.5ml vacc inj pfs
1404000G0AAAFAF
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 20 |
|
Rabies vacc inj 1ml pre-filled syringes
1404000N0AAAFAF
|
Rabies vaccine | Rabies | Immunological Products and Vaccines | 20 |
|
Infanrix Hexa vacc inj 0.5ml pre-filled syringes
1404000F0BQAAAZ
|
Infanrix Hexa | Diphtheria | Immunological Products and Vaccines | 18 |
|
Hib/Meningococcal C conj vacc inj 0.5ml vials
1404000AFAAAAAA
|
Haemophilius influenzae B/meningococcal C | Haemophilus influenzae B/meningococcal C | Immunological Products and Vaccines | 14 |
|
Stamaril vacc inj 0.5ml vials
1404000U0BCAAAA
|
Stamaril | Yellow fever | Immunological Products and Vaccines | 14 |
|
Vaxelis vaccine inj 0.5ml pre-filled syringes
1404000F0BSAABC
|
Vaxelis | Diphtheria | Immunological Products and Vaccines | 14 |
|
dTAP/IPV inj 0.5ml pfs
1404000F0AAAXAX
|
Diphtheria | Diphtheria | Immunological Products and Vaccines | 10 |
|
Havrix Monodose vaccine suspension for injection 1ml vials
140400030BBAEAK
|
Havrix | Hepatitis A | Immunological Products and Vaccines | 10 |
|
Meningococcal polysacch A, C, W135 & Y conj vacc inj 0.5mlvl
1404000X0AAAHAH
|
Meningococcal A, C,W135 and Y vaccine | Meningococcal A + C + W135 + Y vaccine | Immunological Products and Vaccines | 10 |
|
Hepatitis B (rDNA) 10micrograms/1ml vacc inj pfs
1404000G0AAAEAE
|
Hepatitis B | Hepatitis B | Immunological Products and Vaccines | 9 |
|
Varicella immunoglobulin 250mg solution for injection vials
1405020C0AAAAAA
|
Human anti varicella-zoster | Varicella-zoster immunoglobulin | Immunological Products and Vaccines | 9 |
|
Measles, Mumps and Rubella vacc (live) susp inj 0.5ml pfs
1404000W0AAADAD
|
Measles, mumps and rubella | Measles, mumps and rubella vaccine | Immunological Products and Vaccines | 7 |
|
Tetanus immunoglobulin human 250unit inj vials
1405020A0AAABAB
|
Tetanus immunoglobulin | Tetanus immunoglobulin | Immunological Products and Vaccines | 7 |
|
VAQTA Adult vaccine suspension for injection 1ml vials
140400030BDADAK
|
VAQTA | Hepatitis A | Immunological Products and Vaccines | 7 |
|
Hum papillomavirus (type 6, 11, 16, 18) vacc (ads) inj 0.5ml
1404000AHAAAAAA
|
Human papillomavirus (Type 6,11,16,18) | Human papillomavirus (Type 6,11,16,18) | Immunological Products and Vaccines | 6 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.